
Loading, please wait...

Loading, please wait...

Hepatitis C virus (HCV) utilizes physiological lipid uptake pathways for its entry into hepatocytes. Specifically, the virus interacts with several HCV lipoprotein receptors to facilitate attachment and internalization. These include the low-density lipoprotein receptor (LDLR), very low-density lipoprotein receptor (VLDLR), and scavenger receptor class B type I (SR-BI). This interaction mimics native lipoprotein uptake, allowing the virus to infect host cells efficiently while evading immune detection.
The entry process involves a complex and interdependent network of host factors. Besides lipoprotein receptors, the virus requires essential entry factors like CD81, claudin-1, and occludin. Consequently, this dynamic network enables viral attachment and shapes viral tropism. Furthermore, these interactions ensure the virus primarily targets the liver, which is the main site of lipid metabolism.
Recent high-resolution structural insights have transformed our understanding of viral entry mechanisms. Specifically, the structures of LDLR and its complex with apoB-100 provide a clear molecular framework. These models show how viral particles engage HCV lipoprotein receptors by mimicking natural apolipoproteins. Moreover, this structural mimicry explains how HCV successfully exploits metabolic pathways for its own survival. However, some questions regarding the precise kinetics and sequence of these interactions remain a subject of ongoing study.
Understanding these mechanisms is crucial for developing new antiviral strategies. Specifically, clarifying the precise role of SR-BI could lead to the development of novel entry inhibitors. Additionally, researchers are investigating how these receptors contribute to the overall interdependence of the entry network. Therefore, ongoing structural biology research continues to illuminate the path for future therapeutic interventions against chronic infection.
The primary receptors include the low-density lipoprotein receptor (LDLR), the very low-density lipoprotein receptor (VLDLR), and scavenger receptor class B type I (SR-BI). Together with factors like CD81, they form a coordinated entry network.
HCV associates with host apolipoproteins to form lipoviral particles. Consequently, these particles engage lipoprotein receptors by mimicking the structure and behavior of native lipoproteins like LDL and VLDL.
SR-BI acts as a critical attachment and entry factor. Specifically, its lipid transfer activity likely contributes to the structural changes in the viral envelope required for successful cell penetration.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional opinion. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Ebersberger N et al. Lipoprotein receptors in hepatitis C virus entry - a structural view. Curr Opin Virol. 2026 May 12. doi: undefined. PMID: 42119247.
Yamamoto S, et al. Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus. PLoS Pathog. 2016;12(5):e1005611.
Lyu J, et al. Roles of lipoprotein receptors in the entry of hepatitis C virus. World J Gastroenterol. 2015;21(42):12101-11.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A review of the structural mechanisms by which HCV utilizes lipoprotein receptors like LDLR and SR-BI for cell entry and viral tropism....
3 months ago

A clinical comparison of extravascular and subcutaneous implantable cardioverter-defibrillators, detailing patient selection, pacing capabilities, and implantation nuances.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today